Residential greenness and atopic dermatitis in Japanese children: Findings from the TMM BirThree cohort study Background Atopic dermatitis (AD) is a chronic inflammatory skin disease that primarily develops during childhood. Residential greenness has been reported to be associated with AD onset. However, fi.....

【New paper】
In the first large-scale study from Japan 🇯🇵, higher residential greenness🌿 was associated with a lower risk of atopic dermatitis up to age 5.
Satellite-derived NDVI 🛰️ and a birth cohort of 14,932 children
onlinelibrary.wiley.com/doi/10.1111/...

#PediatricAllergy #GIS #ToMMo

Oral Immunotherapy Helps Many Kids Lose Food Allergies, Studies Say MONDAY, Nov. 10, 2025 (HealthDay News) — Evidence is mounting that oral immunotherapy can help many children shake off food allergies.Children benefited from be

Lamya Jaigirdar, DO, and Rachel Kado, MD, discuss new findings on oral immunotherapy for pediatric food allergy. https://ow.ly/fV5S50XrToT

#MedicalResearch #PediatricAllergy

Peanut Oral Immunotherapy Response Linked to Gut Immunity in Children Research links Treg activity, B-cell suppression, and gastrointestinal immune regulation to the success and failure of peanut oral immunotherapy.

Multi-omics profiling links regulatory T-cell activity, B-cell suppression, and gastrointestinal immune regulation to peanut oral immunotherapy success. #PediatricAllergy #PeanutOIT #Immunology

New insights into the mechanisms of childhood food allergies IgE-mediated food allergies are common and can be life-threatening, especially for children. With increasingly rapid advances in immunological technologies, including the ability to profile highly co....

Excited to share our latest publication titled "New insights into the mechanisms of childhood food allergies" in Pediatric Allergy and Immunology

#foodallergy #PediatricAllergy #oralimmunotherapy #allergy #Pediatrics

onlinelibrary.wiley.com/doi/10.1111/...

FDA Approves Odactra for Pediatric House Dust Mite Allergy FDA expands Odactra approval to children aged five to 11 for house dust mite allergy.

The FDA has expanded the approval of Odactra, a sublingual immunotherapy tablet, to include children aged 5-11 with house dust mite allergies. A new treatment option is now available for pediatric patients. Learn more about this approval. #PediatricAllergy #MedSky